|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
|
CA2363965C
(en)
*
|
1991-03-11 |
2010-05-18 |
Curis, Inc. |
Protein-induced morphogenesis
|
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
|
US6498142B1
(en)
*
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
AU743510B2
(en)
|
1997-05-05 |
2002-01-24 |
Stryker Corporation |
Therapies for acute renal failure
|
|
WO1998050061A1
(en)
*
|
1997-05-07 |
1998-11-12 |
Biogen, Inc. |
Novel therapies for cystic kidney disease
|
|
EP0896825B1
(en)
|
1997-08-14 |
2002-07-17 |
Sulzer Innotec Ag |
Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
|
|
US6203788B1
(en)
*
|
1997-09-29 |
2001-03-20 |
Adherex Inc. |
Compounds and methods for regulating cell adhesion
|
|
AU1706499A
(en)
*
|
1997-12-04 |
1999-06-16 |
Curis, Inc. |
Maintenance of smooth muscle integrity by morphogenic proteins
|
|
JP2002526034A
(ja)
*
|
1998-07-28 |
2002-08-20 |
ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン |
増殖分化因子−１１
|
|
US7087577B2
(en)
*
|
1998-10-16 |
2006-08-08 |
Zimmer Orthobiologies, Inc. |
Method of promoting natural bypass
|
|
US6992066B2
(en)
*
|
1998-10-16 |
2006-01-31 |
Zimmer Orthobiologics, Inc. |
Povidone-containing carriers for polypeptide growth factors
|
|
NZ517781A
(en)
*
|
1999-09-14 |
2004-01-30 |
Biogen Inc |
Therapies for chronic renal failure using one or more integrin antagonists
|
|
US20020173453A1
(en)
*
|
2000-12-15 |
2002-11-21 |
Rama Akella |
Method of treating renal injury
|
|
US7700819B2
(en)
|
2001-02-16 |
2010-04-20 |
Kci Licensing, Inc. |
Biocompatible wound dressing
|
|
US7763769B2
(en)
|
2001-02-16 |
2010-07-27 |
Kci Licensing, Inc. |
Biocompatible wound dressing
|
|
US7232802B2
(en)
*
|
2001-12-21 |
2007-06-19 |
Zimmer Orthobiologics, Inc. |
Compositions and methods for promoting myocardial and peripheral angiogenesis
|
|
US7622562B2
(en)
|
2002-06-26 |
2009-11-24 |
Zimmer Orthobiologics, Inc. |
Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
|
|
JP2006516020A
(ja)
*
|
2002-08-28 |
2006-06-15 |
キュリス インコーポレイテッド |
慢性腎不全の治療におけるモルフォゲン及びａｃｅ阻害薬の共投与
|
|
US7576052B2
(en)
|
2003-10-17 |
2009-08-18 |
Joslin Diabetes Center, Inc. |
Methods and compositions for modulating adipocyte function
|
|
US7844367B2
(en)
|
2003-12-23 |
2010-11-30 |
Rain Bird Corporation |
Code replacement for irrigation controllers
|
|
AU2005228696B2
(en)
|
2004-03-30 |
2010-06-24 |
Relypsa, Inc. |
Methods and compositions for treatment of ion imbalances
|
|
JP2008500816A
(ja)
*
|
2004-03-31 |
2008-01-17 |
ゼンコー・インコーポレイテッド |
改善された性質を有するｂｍｐ−７変異体
|
|
WO2006130690A2
(en)
|
2005-06-01 |
2006-12-07 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
|
EP3536704B1
(en)
|
2005-11-14 |
2021-08-25 |
Boehringer Ingelheim Animal Health USA Inc. |
Gene therapy for renal failure
|
|
US7771995B2
(en)
*
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
US20090004159A1
(en)
*
|
2006-01-24 |
2009-01-01 |
The Board Of Trustees Of The University Of Illinoi |
Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
|
|
WO2007087570A2
(en)
|
2006-01-24 |
2007-08-02 |
Northfield Laboratories, Inc. |
Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
|
|
US20080090765A1
(en)
*
|
2006-05-25 |
2008-04-17 |
The Trustees Of Columbia University In The City Of New York |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
|
|
ES2379603T3
(es)
|
2006-05-30 |
2012-04-27 |
Antibodyshop A/S |
Métodos para la evaluación rápida de la gravedad de un traumatismo
|
|
US7722665B2
(en)
*
|
2006-07-07 |
2010-05-25 |
Graft Technologies, Inc. |
System and method for providing a graft in a vascular environment
|
|
WO2008010556A1
(fr)
*
|
2006-07-21 |
2008-01-24 |
Chugai Seiyaku Kabushiki Kaisha |
Médicament agissant contre une maladie rénale
|
|
US20080255181A1
(en)
*
|
2006-12-15 |
2008-10-16 |
University Of Heidelberg |
Methods for treating podocyte-related disorders
|
|
WO2008134297A2
(en)
*
|
2007-04-24 |
2008-11-06 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Engineered renal tissue
|
|
DE102007034580B4
(de)
*
|
2007-07-13 |
2012-11-08 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen |
Biomaterial basierend auf einem hydrophilen polymeren Träger
|
|
US20090155245A1
(en)
*
|
2007-12-18 |
2009-06-18 |
Fang Carrie H |
Treatment for Organ Regeneration with Combination of Drug and Biologics
|
|
JP2011523357A
(ja)
*
|
2008-05-06 |
2011-08-11 |
ジョスリン ダイアビーティス センター インコーポレイテッド |
褐色脂肪細胞分化を誘導するための方法および組成物
|
|
JP5485885B2
(ja)
*
|
2008-06-24 |
2014-05-07 |
株式会社根本杏林堂 |
薬液注入装置、この薬液注入装置を有する透視撮像システム、薬液注入装置のコンピュータプログラムおよびデータ処理方法
|
|
CN105067819B
(zh)
*
|
2008-08-28 |
2018-05-22 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
CN105021826A
(zh)
*
|
2008-08-29 |
2015-11-04 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
AU2009308497B2
(en)
*
|
2008-10-21 |
2014-10-23 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ619918A
(en)
*
|
2008-10-21 |
2015-04-24 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR20110084286A
(ko)
|
2008-11-10 |
2011-07-21 |
아스튜트 메디컬 인코포레이티드 |
신손상 및 신부전의 진단 및 예후 예측을 위한 방법 및 조성물
|
|
CA2743253A1
(en)
*
|
2008-11-22 |
2010-05-27 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US9229010B2
(en)
|
2009-02-06 |
2016-01-05 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN104111336B
(zh)
*
|
2009-02-06 |
2017-01-18 |
阿斯图特医药公司 |
肾损伤和肾衰竭的诊断及预后
|
|
AU2010213575B2
(en)
*
|
2009-02-12 |
2013-11-14 |
Stryker Corporation |
Peripheral administration of proteins including TGF-beta superfamily members for systemic treatment of disorders and disease
|
|
EP2396026A2
(en)
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
|
|
WO2010103070A2
(en)
|
2009-03-12 |
2010-09-16 |
Charité - Universitätsmedizin Berlin |
Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
|
|
WO2010144696A1
(en)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
|
US8871459B2
(en)
|
2009-08-07 |
2014-10-28 |
Astute Medical, Inc. |
Method for evaluating renal status by determining beta-2-glycoprotein 1
|
|
AU2010295509A1
(en)
|
2009-09-17 |
2012-04-19 |
Stryker Corporation |
Buffers for controlling the pH of bone morphogenetic proteins
|
|
US10324093B2
(en)
|
2009-11-07 |
2019-06-18 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ600828A
(en)
|
2009-12-20 |
2014-09-26 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2785038A1
(en)
|
2009-12-22 |
2011-07-21 |
Stryker Corporation |
Bmp-7 variants with reduced immunogenicity
|
|
SI2666872T1
(sl)
|
2010-02-05 |
2016-08-31 |
Astute Medical, Inc. |
Postopki in sestavki za diagnozo in prognozo ledvične poškodbe in odpovedi ledvic
|
|
KR20140051754A
(ko)
|
2010-02-26 |
2014-05-02 |
아스튜트 메디컬 인코포레이티드 |
신장 손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물
|
|
EP2576587B1
(en)
|
2010-05-24 |
2018-03-21 |
The Trustees of Columbia University in the City of New York |
Mutant ngal proteins and uses thereof
|
|
EP2585825B1
(en)
|
2010-06-23 |
2018-01-10 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR101800596B1
(ko)
|
2010-08-20 |
2017-11-22 |
와이어쓰 엘엘씨 |
디자이너 골형성 단백질
|
|
US9688735B2
(en)
|
2010-08-20 |
2017-06-27 |
Wyeth Llc |
Designer osteogenic proteins
|
|
EP3540440B1
(en)
|
2011-12-08 |
2022-09-28 |
Astute Medical, Inc. |
Methods and uses for evaluating renal injury and renal status
|
|
US10813946B2
(en)
|
2012-10-08 |
2020-10-27 |
Vifor (International) Ltd. |
Potassium binding polymers for treating hypertension and hyperkalemia
|
|
WO2014081980A2
(en)
|
2012-11-21 |
2014-05-30 |
The Trustees Of Columbia University In The City Of New York |
Mutant ngal proteins and uses thereof
|
|
EP4105657B1
(en)
|
2013-01-17 |
2024-09-25 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US8956829B2
(en)
|
2013-01-25 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Human recombinant growth and differentiaton factor-5 (rhGDF-5)
|
|
US9359417B2
(en)
|
2013-01-25 |
2016-06-07 |
Warsaw Orthopedic, Inc. |
Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
|
|
US9051389B2
(en)
|
2013-01-25 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
|
|
US8945872B2
(en)
|
2013-01-25 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
|
|
US9169308B2
(en)
|
2013-01-25 |
2015-10-27 |
Warsaw Orthopedic, Inc. |
Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
|
|
EP2784083A1
(en)
|
2013-03-28 |
2014-10-01 |
Charité - Universitätsmedizin Berlin |
Bone Morphogenetic Protein (BMP) variants with highly reduced antagonist sensitivity and enhanced specific biological activity
|
|
EP3069149B1
(en)
*
|
2013-11-11 |
2022-05-18 |
General Electric Company |
Method for reducing error in rotor speed measurements
|
|
EP2944326B1
(en)
|
2014-05-16 |
2018-11-21 |
Cyanagen Srl |
Tricarbocyanine-cyclodextrin-conjugates and their use for the diagnosis of kidney diseases
|
|
EP3543339A1
(en)
|
2015-02-13 |
2019-09-25 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
AU2017277305A1
(en)
|
2016-06-06 |
2018-12-20 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
|
CN109803977B
(zh)
|
2016-08-17 |
2023-03-17 |
菲克特生物科学股份有限公司 |
核酸产品及其施用方法
|
|
JP2019039673A
(ja)
*
|
2017-08-22 |
2019-03-14 |
セイコーエプソン株式会社 |
時間デジタル変換回路、回路装置、物理量測定装置、電子機器及び移動体
|